In the wake of CDC suddenly changing the definition of vaccine, Governor Brown endorses the Western States Scientific Safety Review Workgroup’s conclusion to vaccinate 5- to 11-year-olds. In an effort to change how we understand the concept of vaccines, the CDC changed their definition to “A preparation that is used to stimulate the body’s immune response against diseases.” Previously, it read, “A product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease.” It is no longer a preventative but a stimulating agent that doesn’t produce immunity.

Governor Brown ignored these implications in her announcement. “This is great news for Oregon children, parents, and families. Vaccination is the best tool we have to protect ourselves and our loved ones. With today’s review by leading doctors, pediatricians, and health experts, Oregon parents and children can be confident in the safety and effectiveness of the Pfizer-BioNTech vaccine for 5-to-11-year-olds. It is completely normal for parents and kids to have questions about vaccines -- I urge you to reach out to your family doctor, health care provider, or pharmacist and get your questions answered today.”

The Western States Scientific Safety Review Workgroup is made up of 18 medical personnel from four states: 12 from California and two from Nevada, Oregon and Washington. The workgroup was formed to review the federal process for recommendations to ensure safety of the COVID-19 vaccinations. They independently review the safety and efficacy of any vaccine approved by the FDA for distribution.

Governor Kate Brown said, “The independent review conducted by this panel of doctors, scientists, and health experts will ensure that a safe and effective COVID-19 vaccine is available to everyone, especially communities that have been disproportionately impacted by this disease.”

A D V E R T I S E M E N T

A D V E R T I S E M E N T

In the November 3 report, the workgroup concluded that a thorough review of the evidence presented to the FDA by Pfizer from their clinical trial in children ages 5-11 years of age was 90% safe for that age group, and therefore, they deem it safe. How did they come to that conclusion?

The Workgroup carefully assessed the safety data for the vaccine, including the absence of any severe adverse events among vaccine recipients in the clinical trial. Reactions were mild, self-limited, similar to those seen in adolescents and adults and with other vaccines routinely recommended for children and were less common in those ages 5-11 years than in those 16-25 years. Based on the substantial experience in older children and adolescents, the Workgroup concluded that the risk of myocarditis following receipt of the lower dose vaccine in children 5-11 years of age is likely to be low. How likely?

Pfizer’s website says, “The landmark Pfizer-BioNTech Phase 3 clinical trial began in late July 2020, recruiting participants aged 12 and over. Close to three thousand participants were adolescents: 2,259 participants were between the ages of 12-15 and 754 participants were 16 and 17 years old. In March 2021, Pfizer and BioNTech dosed the first healthy children in a global Phase 1/2/3 continuous study to learn if the vaccine can produce an immune response against COVID-19, and if it is safe, in children aged 6 months to 11 years.” It appears they never did tests on children under 12, but if they did, however many healthy children they tested, it was only a six-month study.

Oregon is one of a few states that is below 10% likelihood that your kids will get COVID-19, and since September the cases have been dropping for kids nationwide, according to NBC News. Those getting COVID-19 have reported flu-like symptoms. Governor Brown would have you think otherwise.

“The Workgroup concluded the vaccine is safe and effective in this age group, because substantial numbers of children of this age remain at risk of COVID-19 illness and its complications, including hospitalization and death, the Workgroup is confident that the benefits of this vaccine for children ages 5-11 years substantially outweigh any known or likely risks. Therefore, the Workgroup supports its use under Emergency Use Authorization (EUA) as a two-dose series of 10 μg per dose given three weeks apart.”

The take away is verification that 17 out of 18 medical professionals on the workforce can read FDA documents. It is baffling why these four state governors question the FDA findings when the workforce looks no deeper than the FDA, and then publishes uncommittable recommendations.


--Staff Reports

Post Date: 2021-11-03 18:51:10

Last Update: 2021-11-03 21:20:08